TT  NYU Innovation Venture Fund es/entrepreneurship-at-nyu/fund/innovation-v enture-fund.html

     Office Locations:

70 Washington Square South
New York, NY 10012
Phone: 212-998-1212



  • Early
  • Seed



  • Information Technology
  • Media & Digital Media
  • Software & Internet



    The NYU Innovation Venture Fund is a seed-stage venture capital fund created in 2010 to invest in startups founded by and/or commercializing technologies and intellectual property developed by NYU students, faculty and researchers. The Fund will consider proposals from students, faculty and researchers at the College/Graduate School of Arts & Sciences, the Polytechnic Institute, the Courant Institute, School of Medicine, College of Dentistry, Tisch School of the Arts and Stern School of Business, among others. NYU initially capitalized the Fund with more than $3 million--much of which came from the proceeds of the sale of a company previously spun out of NYU--and anticipates this growing to $20 million, with tax-deductible donor contributions. The Fund makes approximately five to six investments per year, from $100,000 - $250,000 each, in partnership with other angel investors and/or venture capital firms. The Fund will recycle investment returns from the successful sale of portfolio companies back into the University to finance further research and spinout ventures.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Dee Dao Associate
    Frank Rimalovski Executive Director
    Jerry Hao Associate


    Portfolio companies include:

        web link

        web link

      Framed Data
        web link

      Keen Home
        web link

        web link

      Orca Phamaceuticals
        web link

        web link

        web link

      TB Biosciences
        web link

      Transparent Healthcare
        web link

        web link


    Recent News: